Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Aldevron Plans Fargo Biologics Campus
Aldevron will begin construction in August of 2019 on a 14-acre biologics campus in Fargo, N.D., where it is currently headquartered. The first phase comprises a two-story, 189,000-sf facility for the manufacture of plasmid DNA, proteins, mRNA, and antibodies. Increasing Aldevron’s GMP and GMP-Source™ production capacity up to tenfold, the structure will connect to the company's existing GMP facility and is expected to be fully operational by early 2021.
The Wistar Institute and University Place Associates Plan Philadelphia Research and Discovery Hub
The Wistar Institute is partnering with University Place Associates to construct a 240,000-sf life science discovery hub in the University City district of Philadelphia. Designed to accelerate innovation by providing shared resources and critical infrastructure, the collaborative project will provide leasable laboratories and offices for biotech firms, research companies, and academic institutions.
WuXi Biologics Constructs Dundalk Single-Use Production Facility
WuXi Biologics began construction in May of 2019 on a $365 million pharmaceutical production facility in Dundalk, Ireland. Sited on 52 acres, the 522,000-sf contract manufacturing center will utilize single-use technologies and processes, enabling cost-effective scale-out and the simultaneous production of multiple batches of varying volumes. Commercial operations are expected to begin in 2022 at the site, which will be the company's first manufacturing plant outside of China.
Hackensack Meridian Health Opens Center for Discovery and Innovation
Hackensack Meridian Health opened the Center for Discovery and Innovation in May of 2019 in Nutley, N.J. Located on the ON3 campus adjacent to Hackensack Meridian School of Medicine at Seton Hall University, the 250,000-sf translational research facility will accelerate the creation of innovative therapeutics for the treatment of cancer, diabetes, dementia, antibiotic-resistant infections, and autoimmune disorders. The center houses the Institute for Regenerative Medicine, the Institute for Multiple Myeloma, and the Institute for Cancer and Infectious Disease.
University of Colorado Breaks Ground on Business & Engineering Expansion
The University of Colorado broke ground in June of 2019 on a $45 million business and engineering expansion in Boulder. Designed by Anderson Mason Dale to break down traditional disciplinary boundaries and foster cross-functional student competencies, the 75,000-sf project includes the creation of an addition linking the College of Engineering and Applied Science and the College of Business.